Navigation Links
"Tomorrow's Health" TV Series Showing the Life Science Industry's Quest to Save and Improve Lives, to Air on Select NBC Stations
Date:11/7/2011

SAN DIEGO, Nov. 7, 2011 /PRNewswire/ -- BIOCOM, the trade group representing Southern California's life science industry, and award-winning Phase 3 Digital have partnered to tell the biotechnology story from discovery through development. Consumers across the U.S. will soon get a glimpse into the exciting and innovative world of medical discovery that brings life-saving therapies, medical devices and diagnostics to patients around the globe. "Tomorrow's Health," a new television series created in partnership with the life sciences industry, explores some of the most exciting and promising new treatments under development.

"Tomorrow's Health" introduces viewers to patients, their doctors, and their struggle to achieve healthier lives. The program reveals the surprising truth about the challenges and obstacles biomedical researchers face in the development of cures and bringing new medicines, medical devices and diagnostics to market.

Created and produced by Phase 3 Digital, in partnership with BIOCOM, "Tomorrow's Health" will run on select NBC stations and other major network and cable channels in top media markets around the U.S. The program will feature a website and social media portals, where consumers can view episodes on demand and gain more information on companies and the featured experts.

For more information on how to be considered as a featured company, sponsorship opportunities, or other information contact Ed Personius at Phase 3 Digital, at (714) 748-0600.


'/>"/>
SOURCE BIOCOM
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
2. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
3. Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals New Publication Series; Essential Deal Trends
4. Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
5. Creabilis Raises €15M ($20M) in Series B Fundraising Round
6. Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
7. SironRX Therapeutics Raises $3.4 Million Series A
8. Peloton Therapeutics Completes $18 Million Series A Financing
9. Health Diagnostic Laboratory Inc. Sponsors Lecture Series in West Palm Beach, Florida
10. Northwest Biotherapeutics Announces Series of Financing Arrangements
11. Naurex Completes $18 Million Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 2017 Shareholder rights law firm Johnson & ... board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... the proposed sale of the Company to Eli Lilly ... small molecules for the acute treatment of migraines. ... signed a definitive merger agreement with Eli Lilly. Under ...
(Date:1/18/2017)... TORONTO , Jan. 18, 2017 /PRNewswire/ - ... life sciences and diagnostics company that develops and ... diagnostics ("SQI" or the "Company"), today announced that ... Markets Inc. ("Kingsdale"), has resigned from its Board ... recent changes to securities regulations that have limited ...
(Date:1/17/2017)... ... January 17, 2017 , ... MS ... The new Balance™ GT Soybean Performance System will combine industry-leading genetics with a ... ingredient in the new Balance® Bean herbicide. The Balance™ GT Soybean Performance System ...
(Date:1/17/2017)... Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... detection of foodborne pathogens today announced the appointment of Mary ... Thomas , the Company,s President and CEO since 2009, who will ... The changes are effective today. In addition, Ms. Duseau ... ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):